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PREFACE 
 
Cancer is one of the leading causes of morbidity and deaths worldwide. In 
2015, 8.8 million cancer-related deaths have been recorded and the number of new 
cases is expected to rise up to 70% in the next two decades. This has a significant and 
unprecedented effect on the economic growth of a country. Therefore, each year 
billions of funds are allocated towards the research and development of new 
therapeutic strategies to combat this growing menace. With the advent of new 
scientific technologies and advancement in molecular cancer research, the future does 
seems promising. Nevertheless, considerable measures need to be taken in order to 
solve key issues revolving around this disease such as late presentation of symptoms, 
development of resistance to available treatments and lack of awareness. 
Targeted therapies such as kinase inhibitors and monoclonal antibodies have 
indeed altered cancer care in recent decades. They have improved the disease 
outcomes in many cancer types but still the most serious challenge often encountered 
in cancer therapy is the development of drug resistance.  It is believed that this 
acquisition of resistance is typically caused by small population of cells in tumor with 
pre-existing alterations, which can drive the resistance. Since the concept of Cancer 
stem cells (CSC) has been introduced in late 90s, its importance in cancer research 
and development of novel anti-cancer therapies is widely accepted. CSC which are 
also known as ‘tumor initiating cells’ represent very small population of tumor 
sharing common properties with normal stem cells. They are unique cells with self-
renewing and tumorigenic potential. Current radio and chemotherapies are able to 
eliminate the bulk of cancer cells but not cancer stem cells since they are endowed 
	   	   	  	  
with specific resistance mechanisms. They give rise to new tumors and metastases 
leading to relapse of the disease. The recurring tumors are more malignant, prone to 
faster metastasis and exhibits enhanced drug resistance. Overall, this leads to therapy 
failure reducing the survival rate of cancer patients. 	  
Previous studies by our group have pioneered a cutting edge method to 
develop cancer stem cells from mouse and human induced pluripotent stem cells 
(iPSCs). The novelty of this method was the use of conditioned medium from cancer 
cell lines to direct the differentiation of iPS towards cancer stem like cells without 
undertaking any supporting genetic modifications. It was hypothesized that 
conditioned medium from cell lines should be enriched with factors released from 
cancer cells thereby mimicking tumor microenvironment. These factors mediated the 
conversion of iPSCs to cancer stem cells. First successful attempt was reported by 
Chen et al in 2012 wherein the conversion of mouse iPScs into cancer stem like cells 
using Lewis lung carcinoma (LLC) cell line conditioned medium was demonstrated. 
miPS cells used in this study was harboring GFP gene in the 5’ untranslated region of 
an important pluripotent gene, Nanog. The resulting cells stably expressed GFP in 
undifferentiated state corresponding with the Nanog expression but lost its expression 
once differentiated. Intriguingly, the miPSCs survived the treatment with conditioned 
medium for four weeks and the resulting cells (termed as miPS-LLCcm) expressed 
key markers of stemness and self-renewal such as Nanog, Eras, Rex1, Cripto 
respectively. Furthermore, these cells fulfilled the primary criteria of cancer stem cells 
by exhibiting sphere forming ability in suspension cultures and tumorigenicity in 
balb/c nude mice (1).  
Another study by Yan et al in continuation with the previous study 
demonstrated that tumor derived extracellular vesicles (tEVs) isolated from 
	   	   	  	  
conditioned medium of LLC cells alone facilitated the conversion of miPScs to CSC-
like cells. The resulting cells (termed as miPS-LLCev) were observed to be similar in 
morphology and stemness when compared with miPS-LLCcm. These cells generated 
malignant liposarcoma and extensive angiogenesis when subcutaneously transplanted 
into balb/c nude mice. The results indicated that tEVs and/or other soluble factors are 
instrumental in supporting the differentiation of miPS-LLCcm. This study supported 
our hypothesis that CSC like cells or miPS-LLCcm and their differentiated progenies 
establishes a niche regulating their self renewal and thereby supporting its own 
sustenance in presence of tumor niche derived factors (2). Matsuda et al further 
reinforced this concept by showing that GFP+ miPS-LLCcm could differentiate into 
GFP- vascular endothelial lineage that together with other differentiated cells 
supported the maintenance and differentiation of miPS-LLCcm (3).  
A pioneering work by Sanchez et al has provided interesting insights at the 
transcriptomic level of pancreatic CSCs generated from miPSCs following treatment 
with conditioned medium derived from human pancreatic cancer cell lines. In this 
study the in vitro converted cancer stem-like cells were enriched via subcutaneous 
transplantation in nude mice just like previous studies but subsequent transplantations 
were conducted directly into pancreas. Intriguingly, this orthotropic transplantation 
lead to the enrichment of pancreatic cancer stem cells which in turn generated tumors 
imitating pancreatic ductal adenocarcinoma phenotype (PDAC) with liver metastasis. 
The RNA sequencing analysis of the cancer stem cell line established indicated 
members from the transcriptional pancreatic progenitor network Pdx1, Hes1, Foxa2, 
Hnf1a, Hnf4a, Pax6, Nr5a2, Rbpj, Rbpgl, MafA and MafB were found to be expressed 
together with PDAC related hallmarks such as Kras, Krt19, Col8a1, Col1a1, Cxcr4, 
Muc1, Muc5aC, Mmp2 or Malat1 as well as the most representative pancreatic CSC 
	   	   	  	  
markers CD133, CD24a, EpCAM and CD44. This study clearly indicated the crucial 
role of tumor microenvironment in deciding the fate of cancer stem cells and its 
lineage (4). 
The present work discussed in this thesis is based on the inference drawn from 
the previous findings that in vitro generated CSC from iPSCs is a cutting edge model 
to understand role of tumor microenvironment in the maintenance of CSCs and their 
differentiated progenitor cells. In this study, the CSCcm or cancer stem cell lines 
generated from miPSCs on treatment with breast cancer cell line conditioned medium 
have been utilized to trace the functional roles of CSCs in subcutaneous and 
orthotropic tumor models respectively. This thesis is divided in to three chapters and 
each chapter is further subdivided into three sections: Abstract, Introduction, 
Observation & Results and Discussion.   
In chapter 1, the establishment of CSC-like cell line from miPSCs is discussed. In this, 
human breast cancer cell lines, T47D and BT549 each representing different 
hormonal subtypes have been utilized to derive the respective conditioned medium. 
The miPSCs were exposed to the respective conditioned medium and the CSC-like 
cells were enriched by serial subcutaneous transplantations in nude mice. The 
resulting CSC-like cells had been characterized by morphological, histophathological 
and molecular techniques.    
Chapter 2 deals with the experiments using iPSC-derived CSC model, which 
demonstrates that the cancer-associated fibroblast, a key component of stromal 
microenvironment, originates from cancer stem cells. These findings are the first to 
reported in literature and provide insights in to the ability of CSC to generate a self 
sustaining niche in the presence of tumor derived soluble and/or paracrine factors.  
	   	   	  	  
In chapter 3, generation of a potential breast cancer stem cell model using miPSC-
derived CSC is discussed. The in vitro converted CSC-like cells were orthotropically 
transplanted in to mammary fat pad of female nude mice and the resulting primary 
cells were analyzed for the expression of key breast cancer stem cell markers. This 
study attempts to develop a useful murine breast cancer stem cell model that should 
support in designing novel anti-cancer therapeutics and personalized therapy.    
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CHAPTER 1 
IPSC DERIVED CANCER STEM CELL MODEL 
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ABSTRACT 
 
 
In this chapter, the conversion of mouse induced pluripotent stem (miPS) cells into 
Cancer stem like cells is analyzed. For this, the miPS cells were treated with two 
human breast cancer cell lines, BT-549 and T47D derived conditioned medium 
respectively. Since miPS cells used in this study retained green fluorescent protein 
(GFP) gene under the control of Nanog gene promoter; therefore, self-renewing 
undifferentiated CSCs can be distinguished from differentiated CSCs by the presence 
and absence of GFP expression. The resulting CSC-like cells expressing key markers 
for stemnesss and pluripotency were enriched by serial subcutaneous transplantation. 
This study is based on the previously established protocol to generate CSC-like cells 
from miPS by Chen et al using conditioned culture medium from mouse cancer cell 
lines, suggesting that the medium contains a rich source of factors that are secreted 
from mouse cancer cells and have potential to mimic the tumor microenvironment.  
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INTRODUCTION 
 
 
Concept of Cancer stem cells  
 
In the past two decades, cancer research has witnessed several key milestones 
to control the growing menace of cancer. These have significantly improved our 
understanding of the molecular and cellular mechanisms underlying cancer 
progression but how tumor evades therapies is still elusive. The recent emergence of 
the concept of Cancer stem cells (CSC) has provided with interesting insights in the 
development of effective therapeutic strategies to deal with drug resistance and 
metastasis in tumor cells.  
Normal stem cells and CSC both exhibit self-renewal capacity but this 
capacity is typically deregulated in CSC. They represent a distinct population in 
tumor with self-renewal and tumorigenic potential promoting metastasis and disease 
progression. There are several theories revolving around the development of cancer. 
Clonal evolution theory or stochastic model proposes that tumors are biologically 
homogenous and cells acquire heterogeneity by random accumulation of mutations 
and genetic alterations occurring either stochastically or randomly neoplastic cells. 
This leads to generation of benign or highly aggressive tumors depending on the type 
of genetic alteration acquired by the cells in the tumor. In contrast, the CSC model or 
hierarchical model argues that the cellular heterogeneity emanates from CSC. The 
CSC is biologically distinct from the rest of the cells and occupies the apex position in 
the hierarchy. Several reports supporting this model have demonstrated that in a given 
tumor non-differentiated tumorigenic cells gives rise to more differentiated cells.  The 
tumor-initiating cells can be identified and purified from the bulk nontumorigenic 
population based on intrinsic characteristics.These differentiated cells were unable to 
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form tumors when compared with the their non-differentiated counterpart. Although, 
stochastic model can accommodate the existence of functional CSC, but the striking 
difference from the hierarchy model is that every cell is believed to possess the CSC 
potential (5). 
 
      
Fig. 1  Models of tumor heterogeneity. Courtesy: J.E Dick. Looking ahead in 
cancer stem cells research. Nature Biotechnology, 27:44-46. 2009  
 
 
Both the models seem to be mutually exclusive but recent evidences are 
suggesting that both clonal evolution and hierarchical model should be considered 
simultaneously in defining the tumor heterogeneity. For example, Anderson and co-
workers first directly proved the existence of genetic diversity of cancer propagating 
cells within individual ETV6-RUNX1-positive acute lymphoblastic leukemia (ALL) 
patients (6). Several other studies have also indicated that cancer stem cells exist but 
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might evolve over time. An ancestral clone gives rise to at least two clonal lineages 
that evolve independently, with each clone acquiring diverse genetic aberrations; one 
clone emerges as the dominant diagnostic clone, while the other clone gives rise to the 
predominant clone containing additional mutations at relapse (7).  
 
Functional traits of cancer stem cells 
a) Self-renewal potential 
CSC represents a distinct population in a tumor with long term clonal and self-
renewal potential. In vivo transplantation of tumor cells in immunocompromised mice 
is considered a standard assay to determine the presence of CSC. But in many cases it 
fails to completely recapitulate the in vivo condition of tumor often observed in 
human patients. Therefore, in addition to it, in vivo lineage tracing methods have been 
developed used in syngenic tumor mouse models and human xenograft models to 
assess the fate of cancer stem cells in tumors. Owing to their self-renewal potential it 
is considered that CSC gives rise to the non-CSC progeny forming the bulk tumor 
population. 
 
b) Maintenance in quiescent, slow cycling or active states 
Cancer stem cells have been reported to behave like adult stem cells by shuttling 
between quiescent and active states. For example, Trumpp et al have demonstrated 
the existence of quiescent leukemic stem cells (LSCs) in mouse model of acute 
myeloid leukemia (AML). In addition to it, a report has shown correlation between 
slow cycling CSC in breast cancer cells and the frequency of CSC, measured by the 
retention of a membrane dye PKH26 in mammosphere cultures, in tumorigenic 
assays. This feature of CSC is considered to be important in rendering it resistance to 
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most of the therapeutic drugs that majorly affects active cells. Moreover, it has been 
widely hypothesized that the cancer relapse could be attributed to the reactivation of 
the quiescent CSCs population after several years of treatment.  
 
c) Resistance to conventional therapies 
Recent studies have suggested CSC as a main player for chemoresistance against a 
variety of drugs including cisplatin and/or paclitaxel, temozolomide, etoposide, and 
doxorubicin or methotrexate in many types of cancer including gliomas and 
glioblastoma, breast, colorectal, AML, hepatic, lung, bone, pancreatic, ovarian and 
prostate cancers. Thus, the cellular and  
molecular mechanisms underlying the CSC’s chemoresistance have drawn 
accelerating attention for cancer research. (8). Several important features of CSCs 
render it chemoresistant to known therapeutic drugs. Firstly, they have increased drug 
efflux capacity mediated by expression of multi drug resistance (MDR) transporters. 
Second, many reports have suggested that CSC express higher levels of the enzyme 
Aldehyde dehydrogenase (ALDH1) compared with other cellular counterparts. For 
example, in a study highly metastatic breast cancer cells expressed elevated levels of 
ALDH1 and made them resistant to cyclophosphamide. Third, CSC exhibited 
increased resistance to radiation therapy due to increased DNA damage checkpoint 
reponse and DNA repair capacity as evident in CD133 expressing glioblastoma CSC-
enriched population compared with CD133- populations. Lastly, CSC are considered 
capable to counterbalance the harmful effects of radiation induced reactive oxidation 
species (ROS) by expressing free oxygen radicals as observed in breast cancer 
models. Therefore, CSCs are endowed with the ability to counteract the inhibitory 
effects of therapeutic agents (5).  
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Potential biomarkers for identification of CSC 
 
Breast Colon Glioma Liver Lung Melanoma Ovarian Pancreatic Prostate 
 ALDH1 CD24 
CD44 
CD90 
CD133 
Hedgehog-Gli 
activity 
α6-integrin 
ABCB5 
ALDH1 
β-catenin 
activity 
CD24 
CD26 
CD29 
CD44 
CD133 
CD166 
LGR5 
CD15 
CD90 
CD133 
α6-
integrin 
nestin 
CD13 
CD24 
CD44 
CD90 
CD133 
ABCG2 
ALDH1 
CD90 
CD117 
CD133 
ABCB5 
ALDH1 
CD20 
CD133 
CD271 
CD24 
CD44 
CD117 
CD133 
ABCG2 
ALDH1 
CD24 
CD44 
CD133 
c-Met 
CXCR4 
Nestin 
Nodal-
Activin 
ALDH1 
CD44 
CD133 
CD166 
α2β1-
integrin 
α6-
integrin 
Trop2 
Table 1 Cancer stem cells in solid tumours: accumulating evidence and unresolved 
questions. Courtesy; J.L. Visvader, J.E., & Geoffrey. Nature reviews cancer, 8: 755-
768. 2008 
 
Table 1 shows the extensive list of popular markers used for the identification 
and isolation of CSC in solid tumors. However, these markers are not always 
considered reliable and stringent measures must be taken to ensure the purity of the 
isolated populations of CSC. Moreover, recent studies highlight the importance of 
using multiple markers for CSC identification and different approaches for its 
isolation. It is primarily due to the insufficient specificity of the markers. For 
example, CD44 that marks the breast cancer stem cell (BCSC) population has many 
splice variants and which of these variants actually identifies BCSC is highly 
uncertain. Further, widespread intra- and inter- tumor heterogeneity limits the 
specificity of the CSC marker expression. Such inter-tumour heterogeneity is 
observed for CD133, which is a relatively good FACS marker for CSCs, but is also 
frequently inactivated due to CpG island methylation Nevertheless, recent studies 
have successfully characterized and isolated CSC from solid tumors and analyzed its 
functional relevance for designing novel therapeutic drugs (9).  
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Relevance of CSC niche in cancer 
The tumor microenvironment or niche is composed of diverse cells each 
contributing in the maintenance and homeostasis of the neoplastic cells in tumor. Just 
as the normal stem cells depend on its microenvironment for survival, self-renewal 
and differentiation CSCs are not autonomous. They require constant input from its 
surrounding microenvironment or niche. In glioma mouse xenograft model, 
endothelial cells maintain the stemness and tumorigenicity of the glioma CSC through 
notch and other diffusible factors. Some of the supportive endothelial cells were 
actually tumor derived and therefore, it was proposed that glioma CSC could generate 
its own niche. Activin and Nodal are not only produced by pancreatic CSCs, but also 
are secreted by stellate cells stimulating CSCs in a paracrine fashion. In breast cancer, 
mesenchymal cells are thought to support CSCs through a signalling loop dependent 
on the cytokines interleukin 6 (IL-6) and chemokine C-X-C motif ligand 7 (CXCL7), 
whereas in colon cancer myofibroblasts reportedly support CSCs through hepatocyte 
growth factor (HGF). Therefore, it can be postulated that the microenvironment plays 
a crucial role in the maintenance of CSC. Intriguingly, Kerso et al has postulated the 
existence of mutually exclusive model to determine tumor heterogeneity wherein the 
three fields of biology – cancer genetics, epigenetics and tumor microenvironment 
should be studied together to get better understanding of the processes that determine 
stemness and for designing cutting edge therapeutics (Fig 2). These three factors are 
thought to be working simultaneously to control the stemness but at the same time can 
act independently to so the same (10).  
 
Chapter 1 
 
	   9 
                                   
Fig 2. Evolution of the cancer stem cell model  
Courtesy;  Kreso, A., & John E. D.  Cell stem cell 14: 275-291. 2014  
 
Key signalling pathways related with CSC 
Several pathways including PI3K/Akt, PTEN, JAK/STAT, Wnt/β-catenin, 
hedgehog, Notch, NF-κB, Bcl-2 plays important role in enabling CSC maintain their 
stem cell properties. In PI3K/Akt pathway, activation of Akt is reported in cellular 
transformation and tumorigenesis. Silencing or defective mutations of PTEN have 
been observed in various cancers, including T-cell acute lymphoblastic leukemia, 
prostate cancer, melanoma, glioblastoma and endometrial carcinoma.  
The JAK/STAT signaling pathway is also involved in tumor initiation. 
Aberrations in the JAK/STAT pathway have been recognized in many cancers, 
especially leukemia. v-Abl is a strong non–receptor tyrosine kinase that can induce 
the malignant transformation of pre-B cells by affecting the JAK/STAT pathway.  
Nuclear factor kappa B (NF-κB), a transcription factor that regulates the 
expression of multiple genes, participates in numerous cellular responses to stimuli 
such as cytokines, microbial antigens, free radicals and ultraviolet irradiation. An 
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increasing body of evidence has shown that NF-κB affects the expression of several 
apoptosis–related proteins, such as Bcl-xL, Bcl-2, survivin, cellular inhibitors of 
apoptosis (cIAPs), TRAF and cell cycle regulatory components. Aberrant NF-κB 
activation causes cancer development and progression, chemoresistance, chronic 
inflammation and autoimmune diseases. 
 The well-known Notch, Hedgehog and Wnt signaling pathways play 
fundamental roles in maintaining CSC populations. Notch signaling affects self-
renewal and lineage-specific differentiation of normal human breast stem cells, 
Moreover, Notch4 activity is elevated in breast CSCs, and inhibiting Notch4 activity 
can reduce the breast CSC population, thereby suppressing tumor initiation. 
Aberrant regulation of the Hedgehog pathway is associated with numerous 
human malignancies and is a critical factor affecting the outcome of treating the 
disease. Several agents targeting the Hedgehog pathway have shown promising pre-
clinical results and are currently under investigation in phase I and II clinical trials. 
The maintenance of CSC stem cell properties has been shown to be associated 
with the Wnt signaling pathway. Abnormal Wnt/β-catenin signaling has been 
identified in various malignancies, such as leukemia, colon, epidermal, breast and 
cutaneous carcinoma. Human colon carcinoma, one of the best studied tumors, is 
caused by defective mutations in the adenomatous polyposis coli (APC) gene. 
Defective mutations in APC result in the inappropriate stabilization of β-catenin, thus 
activating the Wnt cascade and inducing epithelial cell transformation (11-16).  
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Therapeutic targets in CSC 
Current system of treatment for cancer fails to completely eliminate CSC 
leading to metastasis and cancer recurrence. Therefore, scientists are designing novel 
strategies designed to specifically wipe out the CSC population and by altering the 
niche supporting these cells. Fig. 3 gives a summary of the new promising CSC-
targeting methods (17). 
 
 
                     
Fig. 3  Therapies targetting cancer stem cells.  
Courtesy; Understanding and targeting cancer stem cells: therapeutic implications 
and challenges. Chen, K., Huang, Y. H., & Chen, J. L. Acta Pharmacologica 
Sinica, 34: 732-740. 2013  
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 RESULTS 
 
 
miPS cells survived and proliferated in the presence of cancer cell 
line conditioned medium 
 
Two-breast cancer cell lines, T47D and BT549 were cultured for deriving the 
conditioned medium. Respective culture medium was collected in 5% serum 
condition according to the previously established protocol. Subsequently, the miPS 
cells were treated with this conditioned medium for a period of four weeks by 
changing the medium every second day (Fig. 1a). As control experiments, miPS cells 
were treated with the Normal stem cell medium. In all the parallel experiments, LIF 
(Leukemia Inhibitory Factor) was withdrawn from the culture medium after miPS 
colonies established in feeder-less condition. It was observed that the untreated miPS 
cells failed to survive beyond one week in the presence of normal stem cell medium 
(Fig. 1b). On the contrary the cells rapidly proliferated in the presence of cancer cell 
line conditioned medium. Therefore, this treatment was continued for four weeks. The 
respective converted cells are termed as CM-T47D and CM-BT549. The conditioned 
medium-treated miPS cells proliferated heterogeneously along with a significant 
number of GFP-positive subpopulations.  
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Fig. 1a Representative images of miPS cells and the conditioned medium treated 
cells, CT-T47D and CT-BT549 cells respectively. Scale bars represent 200µm. 
 
 
Fig. 1b Representative images of miPS cells in feeder-less condition. Cells could not 
be maintained without LIF for more than a week. Cells expire with concomitant loss 
of GFP expression. Scale bars represent 200µm (day 0) and 400µm (day7). 
 
Converted cells exhibited features of CSC-like cells 
To test whether the conditioned medium-treated miPS cells still express 
pluripotency markers, the morphologically heterogeneous cells (with both GFP 
positive and negative) for the expression of CSC and pluripotency markers by reverse 
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transcription quantitative PCR (RT-qPCR) were analyzed. It was observed that the 
conditioned medium-treated miPS cells (CM-T47D and CM-BT549) expressed 
Oct3/4 and Sox2, while they did not express Klf4 and c-Myc transgenes, suggesting 
that CM-T47D and CM-BT549 cells could be controlled primarily by other 
undetermined endogenous gene expression (Fig. 1c). Notably, the expression of 
prominent CSC makers such as CD133 and breast epithelial cancer cell marker 
EpCam were expressed 3- to 10-fold higher in both CM-T47D and CM-BT549 
compared to the untreated miPS cells. Sustained expression of GFP also supports 
evidence that CM-T47D and CM-BT549 cells were converted into CSC-like cells. 
 
Fig. 1c  RT-qPCR analysis of the CSC markers CD133 and EpCam, as well as 
pluripotency markers, Oct3/4 and Sox2 in the cells (CM-T47D or CM-BT549) after 
four weeks of the CM treatment. Expression values were normalized to GAPDH and 
compared with untreated miPS cells. RT-qPCR analysis of transgenes, Klf4 and c-
Myc in the CM-treated miPS cells (CM-T47D or CM-BT549) after four weeks of the 
CM treatment and the primary cells (CSCcmBT549 or CSCcmT47D) generated from 
subcutaneous tumors. Agarose gel image shows no amplification products of Klf4 and 
c-Myc. Data are presented as mean ± standard deviation and analyzed using unpaired 
two-tailed student’s t-test. The level of significance was set as **P<0.01, *P<0.05. 
 
Generation of subcutaneous tumor in immunodeficient mice 
At the end of four weeks, 1x 106 cells in Hanks balanced salt solution (HBSS) were 
injected in subcutaneously into balb/c (female) nude mice. All the transplanted mice 
presented rapidly growing tumor reaching up to a volume of 1000mm3 within one 
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month. The primary cells were harvested and maintained in the 1:1 mixture of stem 
cell medium and respective conditioned medium. The primary cells thereafter are 
termed as CSCcmT47D and CSCcmBT549 based on the treatment of miPS cells with 
the respective conditioned medium Further, serial subcutaneous transplantations of 
the primary cells until tertiary level gave rise to tumor with the same vigor thereby 
indicating the enrichment of CSC population and maintenance of tumorigenicity (Fig. 
1d).  
 
                
Fig. 1d Representative images of the subcutaneous tumors formed after 
transplantation of converted cells and the corresponding micrographs of the primary 
cells cultured from excised tumors. Scale bars represent 200µm. 
 
Tumor histopathological analysis 
Hematoxylin and eosin staining of tumor tissue sections revealed high nuclear to 
cytoplasmic ratio and poorly-differentiated glandular structures representative of 
adenocarcinoma.  
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Fig. 1e Histopathological features of primary subcutaneous tumors CSCcmT47D and 
CSCcmBT549 analyzed by H&E staining. Scale bars represent 300µm. 
 
 
Flow cytometer analysis for cancer stem cell markers 
Both the conditioned medium treated miPS cells (CT-T47D and CT-BT549) and 
primary cells cultured from excised subcutaneous tumors (CSCcmT47D and 
CSCcmBT549) were analyzed for the expression of the prominent CSC surface 
markers, CD44 and CD24 respectively using flow cytometer. Marked enrichment of 
CD44+/CD24low was observed in primary cells compared with converted cells 
indicating enrichment of the CSC population in vivo (Fig. 1f).  
	  
CSCcmT47D CSCcmBT549 
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Fig 1f Representative plots and corresponding graphs of flow cytometer analysis 
demonstrating percentage of CD24-/low and CD24+ in CD44+ cells in 1) CT-BT549, 2) 
CSCcmBT549, 3) CT-T47D and 4) CSCcmT47D. Flow cytometer plots are 
representative of three independent experiments.  
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DISCUSSION  
 
The cancer stem-like cells were generated from miPS cells by treating them 
with conditioned medium from two prominent human breast cancer cell lines, BT549 
(claudin low) and T47D (luminal A). These cell lines were originally established from 
invasive ductal breast carcinoma and represent two major hormonal subtypes of breast 
cancer i.e. ER+/PR+/Her2- and ER-/PR-/Her2-. This criterion of choosing the 
conditioned medium from these two cell lines was to facilitate the understanding of 
the effect of diverse tumor niche-derived factors. The conditioned medium treatment 
resulted in the establishment of GFP-expressing cells with enhanced expression of 
CSC markers, CD133 and EpCam indicative of conversion to CSC-like cells. The 
results corroborated with the previous findings wherein pancreatic cancer cell lines 
derived conditioned medium was used to treat the miPS cells. Further, the converted 
cells were morphologically heterogeneous containing GFP+ and GFP- cell 
population. Earlier reports suggest that In vivo transplantation is an important 
platform to identify the tumorigenic potential of CSC and the microenvironment 
provides the right conducive milieu to enrich this population. Therefore, subcutaneous 
transplantation into immunocompromised mice was considered necessary to enrich 
the CSC-like population. Transplanted cells were able to form tumor subcutaneously 
with high nuclear to cytoplasmic ratio and glandular structures representing 
adenocarcinoma. Moreover, subsequent serial transplantations gave rise to tumors 
with the same potential. Of note, no transgene expression of cMyc or Klf4 was 
observed which suggested that CM-T47D and CM-BT549 cells could be controlled 
primarily by other undetermined endogenous gene expression.  Above all, flow 
cytometer analysis of the four weeks conditioned medium treated cells and primary 
cells revealed enrichment of highly tumorigenic CD44+/CD24-/low cancer stem cell 
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population indicative of the fact that conditioned medium exerts the differentiation of 
miPS cell towards cancer stem cell like phenotype and in vivo microenvironment 
further enriches this population. Therefore, this model should be a useful tool for 
studying the hierarchy of CSCs and its progenitors in vitro with further enrichment in 
immunocompromised mice, indirectly supporting to overcome the drawbacks 
associated with isolation and study of CSC from cancer cell lines.  
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CHAPTER 2 
CANCER STEM CELLS AS THE NOVEL POINT OF ORIGIN OF 
CANCER-ASSOCIATED FIBROBLASTS IN TUMOR 
MICROENVIRONMENT 
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ABSTRACT 
 
In the present chapter, the potential of the CSC to generate CAF-like cells 
(CAFLc) in cancerous niche is tested. For this, primary cells from subcutaneous 
tumors (CSCcmT47D and CSCcmBT54) were cultured in serum free condition to 
enrich CSC spheres. These CSC spheres differentiated into various cell types 
including myofibroblast-like cells. The further characterization revealed that the 
myofibroblast-like cells corresponded phenotypically with CAFLc. The present 
findings support our new concept that CSC should be one of the major contributors of 
CAFs in tumor niche.  
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INTRODUCTION 
	  
Tumor microenvironment and Cancer-associated fibroblasts 
The importance of stroma in tumor microenvironment is now considered more 
than beyond being just a physical support for the epithelial cells. They are crucial 
drivers of cancer progression mediating transformation, tumorigenicity, metastasis, 
inflammation and angiogenesis. A typical stroma consists of a variety of cells such as 
endothelial cells, immune cells, adipocytes, mesenchymal stem cells, and many more; 
each playing a distinct yet complimentary role forming a supportive structure for the 
cells residing in tumor. In a normal, non-cancerous TME stromal components play a 
very conducive role; fibroblasts secrete ECM supporting the tissue remodeling, 
adipose cells serves as energy reserves, endothelial cells organize themselves into 
blood vessels transporting oxygen and nutrients, immune cells mediating resistance 
against infections and stem cells like mesenchymal stem cells serving as progenitor 
cells constantly replacing these functional components of stroma. In cancer an 
imbalance in the functional roles of the stromal components is encountered in 
response with the changes in the mutated epithelial cells. This results in 
transformation of the stromal cells into tumor- associated stroma supporting the tumor 
malignancy.  
Cancer-associated fibroblasts (CAFs) are the most abundant cell type in the 
tumor- associated stroma, which in many cases control the disease outcome. Normal 
fibroblast maintains the tissue homeostasis, supports wound healing, senescence and 
inhibit tumor cell growth. However, CAFs reside within the tumor margins and often 
infiltrate the tumor facilitating transformation and tumor progression. In breast and 
pancreatic cancer, they constitute more than 80% of the stromal compartment often 
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responsible for poor disease outcome. In recent years there is a quantum jump in the 
number of publications supporting the role of CAFs in tumor microenvironment is 
evident. Therefore, there is an emerging concept of CAF as architects of “cancer 
pathogenesis” (18). 
 
Biomarkers for identifying CAF 
It is a well-known fact that the heterogeneity of fibroblasts in stromal 
compartment is widespread. Similarly, multiple subpopulations of CAFs are present 
in the tumor milieu In addition to it, CAF also shares several markers with other 
components of the stroma, such as myofibroblasts, myoepithelial cells, mesenchymal 
stem cells and endothelia making it again difficult to identify and isolate them. The 
most widely used and reference marker for acquisition of a CAF phenotype is α-
smooth muscle actin (α-SMA). Additional markers expressed in CAFs include 
fibroblast specific protein -1 (FSP1), vimentin, platelet derived growth factor- α 
(PDGF-α), PDGF-β, Neuron Glial Antigen-2 (NG2), Col1α1, Fibronectin (FN1), 
Podoplanin (PDPN), Prolyl-4-hydroxylase, Metalloproteinases (MMPs), Fibroblast 
activation protein (FAP). These markers are usually upregulated in CAFs. Among the 
downregulated ones are caveolin-1 and laminin (19). However, most of these markers 
are not CAF specific. Recently, markers restricted for CAF identification has been 
reported such as collagen-11 α-1 (COL11A1), Asporin, microfibrillar-associated 
protein 5 (MFAP5) which may become the potential biomarkers for reliable 
identification of CAFs (18). 
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Cellular origin of Cancer-associated Fibroblasts 
The exact cellular origin of CAFs is a widely debated and controversial issue 
due to its apparent heterogeneity. Many origins of CAFs have been proposed in the 
literature and all seem to be relevant in understanding its functional role. One of the 
main sources is considered to be resident normal fibroblasts. The fibroblasts adjacent 
to the tumor acquire CAF phenotype mediated by several factors released by tumor 
cells activating protumorigenic pathways in them such as upregualtion of TGFβ, bone 
morphogentic protein (BMP), Wnt, Sonic hedgehog (Shh), platelet derived growth 
factor (PDGF) and integrin mediated signaling. Recent reports also propose 
Mesenchymal stem cells (MSCs) as possible sources of CAF. Prolonged exposure of 
human bone marrow-derived MSCs to conditioned medium from MDA-MB-231 
breast cancer cells resulted in myofibroblast differentiation characterized by 
expression of CAF markers like α-SMA, vimentin, fibroblast surface protein (FSP) 
and CXCL12/SDF-1 (21). In several mouse models this has been confirmed by using 
labeled bone marrow cells injected into tumor bearing mice. CAF-like cells from bone 
marrow cell origin are present in the vicinity of the tumors. Epithelial cells are 
another plausible sources of CAFs in tumor milieu. This transformation is facilitated 
by epithelial-mesenchymal transition. The resulting mesenchymal like cells exhibit 
CAF-like morphology by expressing CAF markers alongwith residual expression of 
keratin confirming their epithelial origin. Another emerging source for CAFs is 
considered to be endothelial cells. Zeisberg et al has reported that the endothelial cells 
treated with TGFβ exhibit CAF morphology with elevated FSP1 expression with 
concomitant downregulation of endothelial marker CD31 (22). In addition to these, 
adipose derived stem cells have been reported to differentiate into CAF-like cells on 
exposure to conditioned medium from breast cancer cell lines (23). Overall, the 
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possibility for many sources of origin could be the underlying reason for the 
heterogeneity and multifunctional nature of CAFs in TME.  
 
How to define CAF- a cell or state? 
The aforementioned inconsistency in the knowledge of a specific marker to 
isolate CAF followed by its many possible sources of cellular origin, recent reports 
have suggested new definition for CAF. Intriguingly, CAFs in most of the cases have 
been found to be genetically stable. Madar et al defines CAF as a ‘state’ of fibroblast-
like cells found in the vicinity of the tumor that promotes its progression (19). The 
maintenance of ‘CAF state’ is attributed to its continued exposure to factors released 
particularly by cancer cells in tumor niche. Many factors such as genetic mutations, 
epigenetic alterations, and persistent environmental effects have been considered the 
underlying reason for the acquisition of this state. Genetic mutations including loss of 
heterozygosity (LOH) has been reported in microdissected breast stromal tissues. 
Also, studies have shown mutations in P53 and PTEN in the stromal compartment of 
breast cancer patients. Nevertheless, several studies have also demonstrated that 
unlike epithelial cancer cells, genetic alterations, LOH are extremely rare in CAFs (4-
5%) derived from human ovarian and breast tissues. In contrast, epigenetic alterations 
account for many early gene expression changes observed upon acquisition of CAF 
state. For example, TGF-β type II receptor (TGFBR2) is epigenetically silenced in 
70% of prostate cancer patients and in host mouse prostate fibroblasts in murine 
xenograft model due to secretion of IL-6. This epigenetic alteration coincides with 
elevated DNA methyltransferase I (DNMT1) activity and histone H3 Lys9 
trimethylation (H3K9me3). Another way for maintaining the ‘CAF state’ are the 
signals released from tumor cells, which includes release of interleukin 1 (IL-1), 
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tumor necrosis factor (TNF-α). Moreover, Sukowati et al have demonstrated the 
presence of multipotent primary CAF cells in hepatocellular carcinoma-affected liver 
tissue (24). Therefore, all these evidences provide concrete evidence in defining CAF 
as a ‘state’ rather than a cell type.  
 
Role of CAFs in disease progression 
Stromal cells play a significant role in tumor-associated malignancies. 
Normally, fibroblasts favor maintenance of epithelial morphology and constrain early 
dissemination, tumor growth and metastasis. However, CAF plays completely 
opposite roles. CAFs secrete various factors exemplified in figure 4 that mediate 
tumor-promoting effects thereby supporting cancer progression. CXCL12/ SDF1 is a 
chemokine that can induce angiogenesis and enhance proliferative capacity of cancer 
cells.  This CXCL12 secreted from CAF act via TGF-β-regulated CXCR4 in adjacent 
epithelial cells, which in turn activate the AKT pathway eliciting tumorigenesis. 
Furthermore, CAFs secrete ECM modulators such as MMPs like MMP1, which has 
been reported to augment the migration and invasion of cancer cells. CAF secreted 
TGF-β1 activates TGF-β/Smad signaling pathway in breast cancer cells leading to 
acquisition of metastatic potential by cancer cells (18,19). 
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Fig. 4   Multiple secreted factors and resultant phenotypes stimulated by CAFs. 
Courtesy ; Carcinoma-associated fibroblasts: orchestrating the composition of  
malignancy. Gascard, P. Genes & development, 30:1002-1019. 2016 
 
 
Recent studies have documented the contribution of CAFs in mediating the 
acquisition of premalignant phenotypes. One such example is the CAFs promoting the 
conversion of ductal carcinoma in situ (DCIS) to invasive breast carcinoma (IBC) via 
paracrine IL-6 signalling. Similarly, recent interesting studies have revealed the 
contribution of CAFs towards drug resistance by diverse mechanisms. They do so by 
1) altering cell-matrix interaction that control epithelial cell sensitivity towards 
apoptosis, 2) secrete proteins that control epithelial cell survival and proliferation, 3) 
contribute to direct cell-cell interactions where cells can exchange membrane 
fragments and communicate, 4) create physical barrier that facilitate acquisition of 
drug resistance, 5) activate epigenetic plasticity in neighboring cells. Overall, CAF 
plays a multidimensional role in mediating cancer progression (18).  
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Potential therapeutic targets on CAFs 
The current understanding of the effect of CAF on neoplastic progression is 
unprecedented. Therefore, exciting new clinical studies are being designed based on 
targeting CAFs in addition to targeting cancer cells in order to inhibit malignant 
phenotype. Drugs designed fall into two major categories; drugs aimed at 1) reverting 
the CAF phenotype to a normal fibroblast by targeting the pathways such as 
hedgehog, PDGF, or IL-6 CXCR4 signalling. 2) Eliminating CAFs by delivering 
proapoptic molecules using carriers recognizing CAF specific molecules such as 
FAP-specific antibodies or PDGF BH3 mimetics. Ongoing clinical trials are assessing 
the therapeutic value of human CD8+ T cells engineered to target fibroblast activation 
protein (FAP) expressing cells (25). To summarize, simultaneous targeting of tumor 
stroma and epithelial cancer cells with combination therapies may be a successful 
therapeutic approach for treating various cancers and have the added benefit of 
preventing drug resistance.  
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RESULTS 	  	  
Enrichment of primary cancer stem cell population by sphere 
formation 	  
The primary cells cultured from excised tumor as discussed in previous 
chapter were treated with puromycin to deplete nude mice-originated cells 
completely. After the puromycin selection, the primary culture cells showed a high 
number of GFP-expressing colonies surrounded by myofibroblast-like cells. Sphere 
formation assay was set up with CSCcmT47D and CSCcmBT549 cells. GFP 
expressing spheres were observed in 4-5 days. The spheres, which were dissociated 
into single cells, also gave rise to new spheres during serial passage (Fig. 2a).  
 
 
Fig. 2a Representative images of primary and secondary sphere-forming cells from 
tumor-derived primary cells (CSCmT47D and CSCcmBT549) cultured in serum-
free condition. Scale bars represent 200 µm. 
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Tumor spheres exhibited key features of CSC  
RT-qPCR analysis revealed that CSC marker CD133 were 
expressed higher in the cell population from spheres (Sphere-T and 
Sphere-B in Fig. 2b) compared with the primary cells (CSCcmT47D and 
CSCcmBT549), suggesting the enrichment of CSC-like cells. Also, the 
tumorigenicity of the sphere-forming cells was confirmed by the 
subsequent subcutaneous transplantation in to balb/c nude mice. The 
resulting tumors presented highly malignant phenotype, high nuclear to 
cytoplasmic ratio and enrichment of stromal population (Fig. 2c).  
                              
 
 
 
Fig. 2(b) RT-qPCR analysis of CD133 gene expression. The primary cells 
(CSCcmT47D and CSCcmBT549) and their corresponding spheroids (sphereT and 
sphereB) were used for the qPCR. Expression levels were compared with untreated 
miPS cells and normalized to GAPDH. Data are presented as mean ± standard 
deviation and analyzed using unpaired two-tailed student’s t-test. The level of 
significance was set as **P<0.01, *P<0.05. 
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                     CSCcmT47D          CSCcmBT549  
 
  
Fig.2(c) Histopathology of the primary subcutaneous tumor formed by the injection 
of CSCcmT47D and CSCcmBT549 spheres. Scale bars represent 300 µm 
 
Sphere differentiation and separation of myofibroblast-like cells 
To determine the lineage of cells originating from the enriched CSCs, these 
spheres were then cultured and induced differentiation under anchorage-dependent 
conditions by adding respective primary cell-conditioned medium. The conditioned 
medium was collected from either CSCcmT47D or CSCcmBT549 cell culture in 
DMEM containing 5% knockout serum replacement (KSR). The differentiated cells 
resulted in the production of heterogeneous cell population, which are composed of 
sphere-like colonies expressing GFP and surrounding myofibroblast-like cells (Fig. 
2d-e). Furthermore, subpopulation of myofibroblast-like cells was separated using 
mouse feeder-specific magnetic microbeads or Magnetic Activated Cell Sorting 
(MACS). This method enabled to separate the differentiated myofibroblast-like cells 
from the sphere-derived CSC population (Fig. 2f). As control, original miPS cells 
were differentiated to generate fibroblast-like cells according to previously reported 
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protocols. After differentiation, the cells were also separated using magnetic beads in 
order to isolate pure fibroblast cells termed as miPS-fibroblast (Fig. 2g). 
 
 
d)                e) 
Fig. 2(d) Morphology of primary cells generated from CSCcmBT549 spheroids. The 
morphology of adherent CSCcmT47D spheroids was similar to that of CSCcmBT549 
spheroids (data not shown). Scale bar represents 200µm. Fig. 2(e) Representative 
morphology of cells differentiated from CSCcmT47D and CSCcmBT549 spheres 
after two passages. Scale bars represent 200 µm and 400 µm. 
 
 
          
      CSCcmT47D   CSCcmBT549 
Fig. 2(f) Morphology of differentiated cells isolated from primary CSCcmT47D and 
CSCcmBT549 spheroids. The cells exhibited prominent nucleoli with long spindles. 
Scale bar represents 200 µm (lef)9 and 100 µm (right).  
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Fig. 2(g) Morphology of fibroblasts derived from miPS embryoid bodies. Scale bars 
represent 200 µm. 
 
 
Separated myofibroblast-like cells displayed correspondence with 
cancer-associated fibroblast like cells 
Quantitative gene expression analysis was performed by targeting the 
following genes: CAF markers such as Fibroblast specific protein (FSP1), α-smooth 
muscle actin (α-SMA), stromal derived factor-1 also known as CXCL12, 
transforming growth factor (TGFβ1) and platelet derived growth factor (PDGFα), 
alpha-1 type collagen (Col1α1) well as fibroblast-specific marker, vimentin, which 
were upregulated in the myofibroblast-like cells compared to miPS-fibroblast (Fig. 
2h-i). Thus, we named these cells either CSCcmT47D-CAFLc or CSCcmBT549-
CAFLc. In comparison to miPS-fibroblast, CSCcmT47D-CAFLc had increased 
expression of FSP1, CXCL12, TGFβ1, vimentin and PDGF-α, while α-SMA 
expression was undetectable (Fig. 2h and data not shown). On the other hand, 
CSCcmBT549-CAFLc was activated with considerable expression of the CAF 
secretory factors along with α-SMA, vimentin and Col1α1 expression (Fig. 2i). 
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Fig. 2(h) RT-qPCR analysis of CAF markers, FSP1, Vimentin, TGFβ1, CXCL12, 
Col1α1, and PDGFα in CSCcmT47D-CAFLc. Data is presented as mean ± standard 
deviation and analyzed using unpaired two-tailed student’s t-test. The level of 
significance was set as ***P<0.001,**P<0.01 
 
 
      
 
Fig. 2(i) RT-qPCR analysis of CAF markers, FSP1, Vimentin, TGFβ1, CXCL12, and 
PDGFα in CSCcmBT549-CAFLc. Data is presented as mean ± standard deviation and 
analyzed using unpaired two-tailed student’s t-test. The level of significance was set 
as ***P<0.001, **P<0.01, *P<0.05 
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CSC-differentiated CAFs exhibited expression of prominent CAF 
proteins  
Immunofluorescent staining in the separated CAFs for FSP-1, FAP and α-
SMA was performed. The CSCcmBT549-CAFLc populations showed positive 
staining of all the three markers. In contrast, the CSCcmT47D-CAFLc subpopulations 
expressed primarily FSP-1 and FAP but not α-SMA (Fig. 2j).  
 
Fig. 2(j) Representative images of CSCcmT47D-CAFLc and CSCcmBT549-CAFLc 
stained separately with anti-rabbit FSP1, anti-rabbit α-SMA and anti-rabbit FAP 
antibodies. The nuclei were counterstained with DAPI (blue). Scale bars represent 50 
µm. 
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CAF-like cells exhibited invasive potential 
CAFs could lead in the tumor invasive front directing the migration of 
invading cancer cells as demonstrated by GFP-positive CAF cells. 
Therefore, matrigel invasion assay was performed and it confirmed that 
the generated CAFs were highly invasive as compared with miPS-
generated fibroblasts (Fig. 2h). 
 
 
    
Fig. 2(h) CAFLc invasion ability was measured using Matrigel coated transverse 
inserts and the invaded cells were stained with giemsa and counted in several fields in 
triplicate. Scale bar represents 200 µm. The graph indicates quantitative results by 
counting invasive cells. CSCcmT47D-CAFLc and CSCcmBT549-CAFLc had higher 
number of cells invading than control miPS-fibroblasts. Data is presented as mean ± 
standard deviation and analyzed using unpaired two-tailed student’s t-test. The level 
of significance was set as **P<0.01. 
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Lineage tracing by GFP-RNA in situ hybridization in combination 
with immunofluorescence for FSP1 
CSC cells are the source of origin of the differentiating CAFLc, they could be 
multipotent and thereby maintain plasticity in the phenotype. GFP-mRNA signal was 
significantly higher in the nucleus compared to the cytoplasm in addition to FSP-1 
protein expression (Fig.2i). This observation was contrary to the attenuation of GFP 
florescence observed in the CAFLc in primary culture cells. 
 
 
Fig. 2(i) In Situ Hybridization analysis with GFP-RNA probe for GFP-mRNA (red) 
combined with immunofluorescent analysis for FSP1 (green). DAPI staining is shown 
in blue. Strong GFP signal in the nucleus indicates plasticity of the CAF cells. Scale 
bar represents 10 µm. 
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DISCUSSION 
 
The previous studies associated with the establishment of pancreatic CSC-like 
cells had demonstrated that the primary culture cells derived from subcutaneous 
tumors had highly enhanced expression of CSC markers and their associated 
pathways by the RNA sequencing analysis; therefore, it was decided that all the 
further experiments to be carried out using primary culture cells. Moreover, this 
observation was further corroborated with FACS analysis as discussed in the previous 
chapter.  
 
The primary cells were enriched with puromycin treatment since the original 
miPS cells exhibit a puromycin resistance gene. This ensured depletion of the 
contaminating host cells. One of the striking observation notable was the 
establishment of myofibroblast-like cells encompassing the sphere-like cells even 
after repeating dissociation and passaging. Based on these observations, new concept 
is proposed that the close interaction between these subpopulations could be 
indispensable because the cell lineages maintain the defined organization under the 
so-called “self-sustaining” mechanism of CSCs 
 
Several theories regarding the origin of CAF has been proposed in recent 
studies and in our present work we are proposing for the first time that CSC should be 
one of the important contributor of CAF in tumor microenvironment. To prove this 
hypothesis, we are demonstrating this phenomenon in the established CSC model. To 
begin with, the primary CSC-like cells were enriched from adherent cultures by 
sphere formation assay. Sphere-formation is an important property to determine the 
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functional phenotype of CSC population. Likewise, the established CSCs gave rise to 
a significant number of spheres in non-adherent serum-free condition. GFP expression 
ensured better selection of self-renewing spheres from aggregates. Sphere-forming 
CSCs are considered to be more tumorigenic as compared with the adherent 
counterpart. Accordingly, spheres on subcutaneous transplantation generated tumor 
with histopathological adenocarcinoma-like features, confirming their aggressive 
tumorigenic potential.  
 
Since the expression of CD133 is considered to be vital in determining the 
enrichment of CSC population, the gene expression profile revealed 3- to 7-fold 
increase in its expression in the spheres when compared with the adherent primary 
cultures. 
 
In adherent conditions, spheres have the distinctive ability to differentiate and 
proliferate, resulting in various cell types. One of the most distinguishing features 
observed during the CSC sphere differentiation was the proliferation of feeder-like 
myofibroblast cells surrounding undifferentiated population. This differentiation was 
carried out in the presence of primary cancer cell line, CSCcmBT549 or CSCcmT47D 
conditioned medium, collected by replacing FBS with low concentration of knockout 
serum replacement (KSR) medium in DMEM. Recently, numerous differentiation 
studies prefer to use this defined serum-free medium to avoid possible spontaneous 
and uncontrolled differentiation. Therefore, the serum-free primary CSC conditioned 
medium allowed for a slower and more controlled differentiation of spheres in 
adherent condition, enabling the understanding of the cell types that play an important 
role in maintenance of CSC population. The differentiated myofibroblast-like cells 
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were separated from the stem cell population using MACS. The separated cells had 
spindle-shape morphology with prominent nucleoli and the quantitative gene 
expression pattern for phenotypic markers like α-SMA, FSP1, and Vimentin. These 
results revealed that the differentiated myofibroblast-like cells resemble CAFs 
phenotypically.  
 
In order to ascertain that the population does not constitute normal or activated 
fibroblasts, miPS cells were differentiated to fibroblasts using previously reported 
protocols. These fibroblasts were also enriched using the feeder-specific magnetic 
beads. Comparative gene expression analysis between the miPS-generated fibroblasts 
and CSC-derived fibroblasts provides evidence that the CSC-derived fibroblasts 
correspond to CAFs. Moreover, the expression of some of the well-known CAF 
secretory factors like CXCL12, TGF-β1, and PGDFα were up-regulated in CSC-
derived fibroblast cells which promoted cancer cell invasion and progression. 
Concomitant results were obtained from immunocytochemistry of the separated cells 
for FSP, α-SMA and another prominent CAF marker FAP. The transcript level of 
CAF markers was notably up-regulated but did not reflect at the protein level. This 
contradiction could be due to the limitations in in vitro studies related with lack of 
paracrine signaling and inability to mimic a complete prototype of tumor niche. 
Further, the CAF cells had marked invasion ability through matrigel in comparison 
with the iPS generated fibroblasts corresponding with the previous study that CAFs 
isolated and cultured from patient samples were more invasive then tumor cells.  
 
It was interesting to identify distinct subpopulation of CAFLc arising from the 
CSC cells. This study gives novel insight into the fact that heterogeneity between 
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different classes of CAFs could be attributed to their origin from CSCs modulated 
with epigenetic and microenvironmental changes. The populations of CAFs could not 
be maintained after their generation from CSCs for more than five passages. It is 
important to state that on separation, some CAFs subpopulations had the tendency to 
revert back to stem cell state and those fully differentiated did not survive. This 
phenomenon was not observed in case of normal miPS cells. In the primary cells 
CSCcmBT549 and CSCcmT47D, codependent GFP-positive stem cell colonies with 
differentiated fibroblast-like cells survived repeated passages were observed. 
Furthermore, it was observed that the CAF had the ability to switch between a stem 
cell state and a fully differentiated CAF-like state behaving as a supporting niche for 
the CSC sustenance. 
 
Overall, by taking into account all the major observations and results 
regarding the conversion of CSC into CAF-Lc, we demonstrated that CSC could 
possibly be one of the important points of origin for CAF in the tumor niche and 
provides evidence regarding its heterogeneous identity. 
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ABSTRACT 
 
The present chapter demonstrates preliminary studies leading to the 
development of a potential breast cancer stem cell model in immunocompromised 
nude mice. Converted miPS cells using cancer cell line conditioned medium as 
discussed in Chapter 1 has been used in the present study. These cells were 
transplanted orthotropically into mammary fat pad and the resulting tumors were 
analyzed for the enrichment of breast cancer stem cells.  
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INTRODUCTION 
	  
Breast cancer is the leading cause of death in women worldwide. Metastases, 
disease recurrence, resistant to conventional therapies are some significant hurdles in 
the complete evasion of this disease. Nevertheless, recent advancements in better 
screening methods and treatment of breast cancer are indeed hopeful but still there is 
still much to be done for achieving better disease survival rate. There has been a 
growing interest in understanding the role of cancer stem cells in breast cancer 
progression. Its study is providing with key insights in to its functional role in 
imparting drug resistance and metastasis.  
Breast anatomy and physiology 
Breast is a glandular organ with lobular organization. A normal human breast 
arises from the primary ectodermal growth in the second trimester of embryonic life. 
A typical breast lobe has a single lactiferous duct, which branches into several 
segmental ducts, ending into several terminal ducts and lobules, which represent the 
terminal ductal lobular units, TDLU. The ducts and ductules are lined by an inner 
layer of cuboidal to columnar epithelial cells and an outer layer of myoepithelial cells. 
The connective tissue within the lobule is composed of fibroblasts in a background of 
collagen and acid mucins, with histiocytes and occasional lymphocytes. The 
interlobular stroma is hypocellular and composed of fibroadipose tissue. The 
epithelium and lobular stroma are hormonally responsive. 
The number of lobes and the basic morphology of the breast remain constant 
in a women’s life but the size and form changes in response to the progressive and 
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regressive morphological processes occurring in response to age and hormonal status. 
During the reproductive period, the female breast undergoes a series of cyclical 
changes related to the menstrual cycle. Increased proliferation of the cells in ducts and 
lobules, which appears primarily in the luteul phase, leads to increased epithelial cell 
number and an increased number of acini per lobule; new bud formation from the 
terminal ducts increases the number of lobules. At the end of menstrual cycle, 
genetically programed cell death or apoptosiss appears in epithelial and myoepithelial 
cells and the process reverts to a status similar with the beginning of the menstrual 
cycle.  
The mammary gland attains its full development in pregnancy with a 
substantial increase in the lobule number, size, and number of acini per lobule. After 
lactation, the mammary glands regress via collapse of the acini and small ducts, 
apoptosis of their epithelium and myoepithelium, and regeneration of the elements of 
interlobular stroma. During and after menopause, parenchyma undergoes involution 
resulting into diminished number of lobules, acini per lobules and terminal ducts in 
addition to stromal involution (26). 
Deome et al first suggested the existence of self-renewing multipotent stem 
cells. It was hypothesizes that the entire mammary gland could be regenerated from 
the random fragments of breast epithelium (27). Furthermore, its also suggested that 
there is three distinct population of epithelial progeny cells in the breast: one capable 
of producing all epithelial cells and the other either give rise to secretory lobules or 
branching ducts. Therefore, the development and maintenance of breast lobes could 
be attributed to the complex processes involving several types of stem cells/ 
progenitor cells (28). 
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Fig. 1 a) Anatomy of the human mammary gland. b) Each duct is lined with a layer of 
epithelial cells and surrounded by an outer layer of myoepithelial cells. The glandular 
ducts are embedded in fibroblast stroma c) this structure breaks down in breast 
cancer, resulting in an epithelial cell mass. b) and c) are immunostained using 
antibodies to the estrogen receptor (ER; brown stained nucleus) showing that only a 
small portions of epithelial cells are ER+ in the normal breast. Courtesy: Ali et al; 
Nature Reviews Cancer, 2:101-112. 2002 
 
Breast cancer and its classification 
Cancer that affects the breast tissue is named as breast cancer. Since it is a 
complex heterogeneous tissue therefore in the breast cancer classification, profiling is 
performed on the basis of various criteria. The major categories are based on the stage 
of the tumor, grade of the tumor, expression of specific hormone receptors, genes or 
proteins and on the basis of histopathology types. Most studies divide breast cancer 
into four major subtypes: 
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1. Luminal A – The cancer starts in the inner lining (luminal cells) of 
the mammary ducts. They tend to be positive for hormone receptors 
such as Estrogen-positive (ER+), Progesterone-postive (PR+) and 
herceptin receptor 2 negative (Her2-). Of all the subtypes this has the 
best prognosis and highest survival rate.  
2. Luminal B – They are usually ER- and Her2-/+. This subtype has 
comparatively lower survival rate depending on tumor size, tumor 
grade and number of lymph nodes.  
3. Triple negative breast cancer – They are ER-/PR- and Her- and 
considered as the most aggressive with poorest prognosis type of 
breast cancer. Most of the triple negative breast cancers are basal-
like.  
4. Her2 type – Most of this subtype are Her2+ and some can be Her2- 
but they are ER-/PR-/Her2-. They correspond with poor tumor grade 
and lymph node positive.  
Breast cancer stem cells 
Neoplastic changes in cells are considered to be the result of a series of 
changes pertaining to disturburance in the cellular homeostasis and errors during cell 
cycle. A malignant tumor is composed of a heterogeneous population of mutant cells 
whose genotype and phenoytpe differs from the normal cell. But recent studies 
provides evidence that the tumors also consists of slow dividing cancer stem cells 
significantly controbuting towards the onset of tumorigenesis. Though they share 
similiarities with the normal stem cells but are not necessarily originated from stem 
cells. The main criteria to classify cells as cancer stem cells is based on its ability to; 
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1)  form tumor in immunocompormised mice 2) self-renew by forming tumor in 
secondary mice and 3) differentiate into cells with non-stem cell characteistics. 
Breast cancer is the first human carcinoma for which a putative cancer stem 
cell subpopulation has been isolated. Using cell surface markers, Al Hajj and 
colleagues isolated highly tumorigenic cell population expressing CD44+/CD24-
/lowLin- from in vitro-separated tumorigenic cells from malignant human breast cancer 
derived pleural effusions. These cells had the ability to form tumors in 
immunocompromised NOD/SCID mice compared with  CD44+/CD24+Lin-. They 
shared the classical features of normal stem cells since it could be serially passaged 
(self renew) and formed  heterogenous tumors (29). Another expression based CSC 
enrichment marker Aldehyde Dehydogenase (ALDH) is used to enrich breast CSCs 
population. The combination of measuring ALDH activity (ALDEFUOR assay) with 
the analysis of surface markers, CD44high/CD24- is considered now as more refined 
methodology compared to either method alone. Daidone et al demonstrated the 
generation of non-adherant cells called mammospheres from single cell suspension 
obtained from primary breat tumors (2). These spheres showed positive enrichment of 
mammary cancer stem cells with majority of cells expressing CD44high/CD24-. Due to 
intra- and inter- tumor heterogeneity in breast cancer CSCs from different tumors 
have distinct expression profiles. Thus, isolation and chracterisation of CSC is 
cumbersome and requires a combination of various techniques to ensure isolation of 
pure CSCs (26,28). 
Significance of breast cancer sem cells in cancer progression  
Cancer stem cells are critical therapeutic targets due to its ability to support 
tumor aggressiveness. But breast cancer prognosis varies according to the subtype and 
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intriguingly this variation is also observed with CSC populations. For instance, in 
caludin-low, Her2+ cancers, a gene set enrichment analysis showed that the proportion 
of cells expressing CSC markers was 3-4 folds times higher in undifferentiated 
tumors compared with well-differentiated tumors. Further, a comparative analysis for 
gene signature of surface marker, CD44high/CD24-between tumors cells and 
mammospheres confrimed that claudin-low tumors are enriched for CSCs and related 
with poor prognosis. Similiarly, Her2 expression has been linked to the expression of 
ALDH1 in human breast cancer with poor clinical outcome suggesting a direct link 
between CSC and tumor aggresiveness.  
CSCs have been found to be associated with metstasis in recent studies. They 
play a pivotal role in dissemination and formation of  metastatic lesions leading to 
cancer deaths. This is supported by various histopathological studies wherein a 
significant population of CD44high/CD24- CSC populations was isolated from bone 
marrow lesions.  
Breast cancer recurrence due to resistance to chemotherapy is another hurdle 
encountered in patients. CSCs are resistant to most of the known chemotherapeutics 
such as MCF-7 that is resistant to common drugs such as Adriamycin, 5-Fluorouracil, 
Methotrexate, cis-platinum. Interestingly, Gupta et al had demonstrated the 
enrichment of CSC-like cells on treatment of SUM159 and SUM149 with paclitaxel 
or 5-Fluorouracil respectively (30). Since the EMT mechanism and CSCs  have a very 
close relationship it is often observed that cells undergoing EMT attain resistance by 
upregulating the expression of protein pumps associated with drug resistance. 
Furthermore, CSC helps in tumor maintenance since they differentiate to give rise to 
heterogeneous cell population and recapitulate malignant tumor.  Thus, it is fairly 
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evident that breast cancer stem cells play an indispensible role in cancer disease 
progression and maintenance.  
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RESULTS 
 
Orthotropic transplantation lead to enrichment of CSC-like cells  
miPS cells were treated with conditioned medium derived from T47D and 
BT549 breast cancer cell lines following the similar protocol mentioned in Chapter 1. 
The primary cell line established from the subcutaneous tumors were injected into 
fourth mammary fat pad of female balb/c nude mice. Orthotropic tumors were 
observed within a short span of 25 days. Subsequent serial transplantation until 
tertiary level also generated tumors. The tumors were excised and harvested for 
primary cell culturing termed as T47DMaCSCcm and BT549MaCSCcm. Primary 
cells exhibited GFP+ cancer stem cell like undifferentiated colonies surrounded by 
GFP- cells (Fig. 3a). Metastatic nodes were observed on the lungs in at least 2/3 mice 
indicating metastasis. Lung tissue primary cultures also had GFP+ colonies but its 
number was less (Fig. 3b). This revealed that only a few cells acquired metastatic 
capability and migrated to the lung tissue forming metastatic nodes. 
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Fig. 3a Representative images of orthotropic tumor formed following mammary fat 
pad injection in nude mice and corresponding micrographs showing enrichment of 
GFP+ CSC-like colonies in primary cultures. Scale bars represent 200µm. 
 
 
Fig. 3b Lung metastatic nodes observed in balb/c nude mice harboring orthotropic 
tumor formed by injecting T47D conditioned medium treated miPS cells and 
corresponding representative image of the primary lung culture showing CSC-like 
colony. Scale bar represents 200µm. 
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Characterization of primary cells revealed its correspondence with 
breast cancer stem-like cells 
Quantitative gene expression analysis was performed for breast cancer stem cell 
markers: CD44, ALDHA1 and SOX2. Intriguingly, BT549MaCSCcm cell showed up 
regulation of CD44, ALDHA1 and SOX2 gene expression. Likewise, 
T47DMaCSCcm also revealed similar upregulation indicating positive enrichment of 
breast cancer stem cell population. On analyzing the expression level of Muc1, a 
breast adenocarcinoma marker, distinction was observed. BT549MaCSCcm cells had 
fairly significant expression of Muc1 but in T47DMaCSCcm it was undetectable (Fig. 
3c). Furthermore, flow cytometer analysis confirmed enrichment of CD44+/CD24-/low 
cell population (Fig. 3d).  
 
 
  
	  	  
 
 
 
 
 
 
 
 
Chapter 3 
	  	   54 
 
Fig. 3c qRT-PCR analysis showing enhanced expression of breast cancer stem cell 
markers, CD44 and ALDHA1 in primary cells cultured from tumors in comparison 
with miPS cells. Furthermore, the significant expression of MUC1, prognostic marker 
for metastatic progression and SOX4, master regulator of epithelial-mesenchymal 
transition is observed indicating a malignant breast cancer phenotype. 
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Fig. 3d Identification of breast cancer stem cell population expressing CD24+ and 
CD24-/low in CD44 cells by flow cytometry. BT549MaCSCcm and T47DMaCSCcm 
primary cell lines shows enrichment of CD44+/CD24low breast cancer stem 
population. 
 
Immunohistochemical analysis of orthotropic tumor sections 
The hematoxylin and eosin stained tumor sections confirmed the malignancy of the 
tumors characterized by high nuclear to cytoplasmic ratio and desmoplastic stroma 
(Fig. 3e). Her2/ ErbB2 receptor has recently reported being selectively expressed in 
breast cancer stem cell population in the triple negative subtype of human breast 
tumors. The tumor sections stained with Her2 receptor antibody revealed significant 
upregulation of this receptor in the ductal membranes (Fig. 3f). This indicated a 
enrichment of CSC population in vivo resulting in the generation of malignant 
tumors. Also, the respective tumor sections stained positive for Muc1, a common 
marker for identifying breast adenocarcinoma and epithelial tumors (Fig. 3g). 
Therefore, these results give preliminary evidence that these orthotropic tumors 
corresponded with breast tumors formed by CSC-like cells. 
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Fig. 3e Representative images of Hematoxylin and Eosin (H&E) stained tissue 
section micrographs showing ductal structures in primary orthotropic tumors 
BT549MaCSCcm and T47DMaCSCcm.  
 
	  	  	  
Fig. 3f   Immunographs of tissue sections stained with ErbB2/Her2 receptor 
demonstrated up regulation of Her2 receptor expression confirming enrichment of 
CSC-like cells. 	  	  	  	  
BT549MaCSCcm T47DMaCSCcm 
BT549MaCSCcm T47DMaCSCcm
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Fig. 3g   Immunograph of tissue section stained with Muc1 antibody confirming 
adenocarcinoma like phenotype of T47DMaCSCcm tumors.    	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
BT549MaCSCcm T47DMaCSCcm
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DISCUSSION 
 
Breast cancer is still one of the most pervasive diseases among women 
worldwide. Several therapeutic strategies have been devised but the problem of 
relapse and metastasis hinders its complete cure. The role of breast cancer stem cells 
is perceived as indispensable in the development and progression of this disease. The 
CSC niche maintains a heirarchy of heterogeneous cells, which facilitates the 
inception of the tumor until its invasion. Therefore, present study focuses on the 
development of an effective breast cancer stem cell model from mouse induced 
pluripotent stem cells (miPSCs). The miPSCs were treated with these conditioned 
media separately for a period of one month following the protocol previously 
discussed in chapter 1. The resulting survived cells were orthotopically transplanted 
into fourth gland of female Balb/c nude mice. Within a short span of 20-25 days, 
orthotopic tumors were developed. Therefore, these cells staisfied the key hallmark of 
tumorigencity usually exemplified by CSCs.  
The primary cells cultured from excised tumors had numerous GFP+ colonies 
concomitant with the subcutaneous tumor cultures discussed in chapter 1. Intriuingly, 
the number and undifferentiated state of these colonies was observed to be more 
enhanced when compared with the subcutaneous tumors. This suggested that 
orthotropic microenvironment was more condusive in supporting the CSC-like 
population. This observation was further ascertained by  quantitative gne expresssion 
analysis which showed high expression of breast CSC markers, CD44 and ALDHA1 
respectively. SOX4, a master regulator of epithelial mesenchymel transition is 
considered to be accompanied by an enhanced number of cells with a CD44+/CD24-
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 phenotype and higher invasion and mobility of cancer cells in vivo and in vitro. Its 
expression was highly upregulated in both BT549MaCSCcm and 
T47DMaCSCcm primary cells respectively.	  
 Furthermore, FACS analysis for CD44 and CD24 surface markers was 
performed to analyze the percentage of CD24-/low and CD24+ in CD44+ cells and the 
number of CD44+ and CD24-/low expressing cells was observed to be upregulated. The 
combination of CD44+/CD24-/low and/or ALDH1 is a widely used cancer stem cell 
marker in breast cancer. Therefore, orthotropic transplantation of conditioned medium 
treated miPS cells indeed lead to the generation and enrichment of breast CSC-like 
cells. 
Muc1 is a gene encoding for mucin glycoproteins normally expressed in apical 
surface of mammary epithelial cells. But in many epithelial tumors particularly in 
breast adenocarcinomas its expression is upregulated on the cell surface. Its gene 
expression was observed being enhanced in BT549MaCSCcm but was undetectable 
in T47DMaCSCcm. Nevertheless, immunohistochemical analysis with antibody 
specific for Muc1 on T47DMaCSCcm tumor sections revealed its marked expression 
at protein level.  
Recent studies have reported that CSC population selectively expresses Her2 
receptor and this expression is regulated by the tumor microenvironment. Its blockade 
decreases the CSC population in breast cancer cell lines and mouse xenografts. 
Therefore, immunohistochemistry with Her2 receptor antibody was performed to 
analyze its expression in orthotropic tumor expression. Consistent with the previous 
reports BT549MaCSCcm and T47DMaCSCcm tumors displayed high 
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expression of Her2 receptor on the ductal membrane confirming marked 
enrichment of breast CSC-like cells by orthotropic transplantation.  
The present study provides preliminary results related with the attempt 
to generate a mouse model that recapitulates breast cancer phenotype initiated 
by CSC-like cells. This model should contribute in the better understanding of the 
role of CSCs in development and progression  of breast cancer.
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MATERIALS AND METHODS 
Cell culture 
Two human breast cancer cell lines, T47D (ATCC HTB-133) and BT549 (ATCC 
HTB-122) were revived and cultured in RPMI-1640 (Sigma) medium containing 10% 
fetal bovine serum (FBS; Gibco, NY) and 100 U/ml penicillin/streptomycin (P/S; 
Wako, Japan). The conditioned medium (CM) was collected according to the 
previously established protocol by Chen et al. The cell lines were allowed to grow 
until it becomes 80% confluent in the same medium and then fresh medium 
containing 5% fetal bovine serum was added. The CM was collected and filtered 
using 0.22µm filter (Millipore, Ireland) and stored at -20°C until the time of use. 
miPS (iPS MEF-Ng-20D-17) were purchased from Riken Cell Bank, Japan and 
maintained in DMEM (D5796, Sigma) containing 15% FBS, 0.1 mM MEM non-
essential amino acids (NEAA; Gibco, NY), 2 mM L-glutamine (Nacalai Tesque, 
Japan), 50 U/ml P/S, 0.1 mM 2-mercaptoethanol (Millipore, MA) and 1000 U/ml of 
Leukemia Inhibitory Factor (LIF; Millipore, MA) on feeder layer of mitomycin-
treated mouse embryonic fibroblast (MEF) cells (Reprocell, Japan). The miPS cells 
express GFP controlled under Nanog gene promoter. For conditioned medium 
treatment, the miPS cells were cultured without LIF and MEF feeder cells in the 
presence of CM and miPS medium described above in 1:1 ratio with medium changed 
after every 24 hours for four weeks. The primary cancer stem cell line derived from 
mouse allografts was maintained in the same medium. For CM used for sphere 
differentiation, the primary cancer stem cells were treated with miPS medium, 10% 
FBS and P/S (50 U/ml) for until 80% cell confluence than the medium was changed 
to DMEM containing 5% knockout serum replacement (KSR) (Gibco, NY), 0.1mM 
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NEAA, 2 mM glutamine, 50 U/ml P/S which was collected after the cell confluence 
reached 100%. The CM was centrifuged at 1000 rpm for 5 minutes and filtered using 
0.22 µm diameter pore filter (Millipore, Ireland) and stored at -20°C until the time of 
use.  
Sphere formation and differentiation  
5×104 cells were seeded on 6-cm ultra-low attachment dishes (Corning incorporated, 
NY) with the DMEM medium without FBS but with Insulin-transferrin-selenium-X 
(ITS-X; life technologies, CA), NEAA (0.1 mM), L-glutamine (2 mM) and P/S. After 
3 – 4 days, the sphere-forming cells were collected by centrifuging at 300 rpm for 5 
minutes and suspended in 1✕phosphate buffer saline (PBS). After aspirating PBS, the 
spheres are dissociated by accutase (Sigma, USA) treatment and seeded at the density 
of 104 cells/ml in ultra-low attachment dishes with the above-described medium. 
After 4 days, spheres around 100 µm diameter were seeded in 0.1% gelatin (Sigma)-
coated 6cm adherent dishes in presence of DMEM containing 5% KSR, P/S and 
conditioned medium collected from primary CSC cell line as described above in 1:1 
ratio. Medium was changed every other day and the differentiated cells were 
dissociated and maintained for no longer than 2-3 passage.  
Separation of myofibroblast-like cells  
The myofibroblast-like cells differentiating cells from cancer stem cell populations 
were separated using feeder removal microbeads, mouse, LS column and Midi MACS 
separator (MACS, Miltenyi Biotec, Singapore). After separation, the cells were 
maintained in the same medium containing KSR up to five passages.  
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Animal experiments 
a) Subcutaneous transplantation: Four-weeks-old female nude mice Balb/c-nu/nu 
(Charlesriver, Japan) were subcutaneously transplanted with 106 cells 
suspended in 200 µl of HBSS (Hanks Balanced salt solution, Gibco, NY).  
b) Orthotropic transplantation: Five to six-weeks-old female nude mice Balb/c-
nu/nu were injected unilaterally 5x105 cells in 20 µl of HBSS in to the fourth 
abdominal mammary fat pad by subcutaneous injection at the base of the 
nipple. 
Tumor growth was monitored using vernier caliper for one month and were harvested 
when they reached ~1000 mm3. For assessing tumorigenic ability of tumorspheres, 
spheres from primary cancer stem cell lines were collected and resuspended in 200 µl 
of matrigel matrix (Corning Incorporated, NY) and injected subcutaneously into four 
weeks old nude mice. The plan of animal experiments was reviewed and approved by 
the Animal Care and Use Committee Okayama University under ID OKU2013252, 
OKU2014157, OKU2014429 and OKU2016078. All experiments were performed 
according to the Policy on the Care and Use of the Laboratory Animals, Okayama 
University. 
Histological analysis 
Tumors were excised from mice after four weeks, fixed in 4% paraformaldehye 
(Wako, Japan) and paraffin embedded. The paraffin tumor blocks were sectioned at 
5µm thickness. Following deparaffinization, sections were stained with 0.5% 
Hematoxylin (Sigma Aldrich, USA) and Eosin Y (Sigma Aldrich, USA) for 
histological analysis. 
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Immunohistochemistry  
Deparaffinization of the tumor sections was done by incubating in hot air oven at 
60ºC for 30min and rehydrated using serial treatment with ethanol and xylene. 
Antigen retrieval was performed by treating the sections with 10mM citrate buffer 
(pH6.5) in a water bath at 100ºC for 30min. For quenching endogenous peroxidase 
activity, sections were blocked with 3% hydrogen peroxide (H2O2). Further, slides 
were blocked with PBS + 1.5% normal serum, incubated with primary antibodies 
diluted in 2.5% normal serum overnight at 4ºC for rabbit monoclonal Her2/ErbB2 
(1:100, #CST 2165, Cell Signaling, MA), rabbit monoclonal GFP (1:200, #2956, Cell 
Signaling, MA), rabbit monoclonal MUC1 (1:100, #ab15481, Abcam, UK). 
Following incubation, the sections were washed with PBS and incubated with 
appropriate secondary antibody. Detection of the antibody was accomplished using 
Elite anti-rabbit ABC staining Vectastain kit (Vector, MI) and 3,30-diaminobenzidine 
tetrahydrochloride (DAB, Vector, MI) by following manufacturer’s protocol. Finally, 
sections were counterstained with hematoxylin. Slides serving as negative controls 
were incubated with secondary antibody only.     
Immunofluorescent analysis 
105 cells/ml were seeded on 0.1% gelatin coated coverslips in 24-well culture plates. 
The cells were fixed with 4% paraformaldehye for 20 minutes at room temperature 
followed by permeabilisation with 0.2% Triton-X (Nacalai Tesque, Japan) in PBS. 
After 5 minutes, cells were washed and blocked with blocking buffer (PBS containing 
5% BSA and FBS) for 1 hour. The cells were incubated with primary antibodies; (a) 
anti-FSP-1 (anti-rabbit, 1:300; MerckMillipore, Ireland) (b) anti-α-SMA (anti-rabbit, 
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1:200; Abcam) (c) anti-FAP alpha (anti-rabbit, 1:200; Abcam) for overnight at 4°C. 
Following washes with PBS, cells were incubated with Alexa Fluor 555 donkey anti-
rabbit (1:300, Invitrogen, USA) for one hour. Nuclei were counterstained with 4’, 6-
diamino-3-phenylidole, dihydrochloride (Sigma, USA) and mounted on glass sides 
with Vectashield mounting medium (Vector Labs, USA). Images were acquired using 
Olympus microscope equipped with light fluorescence device (Olympus, Japan). 
RNA extraction and Reverse transcription quantitative PCR (RT-
qPCR) 
Total RNA was extracted from cells using RNAeasy Mini kit (QIAGEN, Germany) 
and treated with DNase I (Invitrogen, USA). 1 µg of RNA was reverse transcribed 
using Superscript First strand kit (Invitrogen, CA). Quantitative PCR was performed 
with cycler 480 SYBR green I Master Mix (Roche, Switzerland) according to 
manufacturer’s instructions. Primers used for qPCR are listed in Supplementary Table 
1. 
Cell Invasion assay 
Matrigel Coated Transwell evaluated the invasion ability of the cells and Transwell 
inserts (Corning Matrigel Invasion chamber). 5×104 cells in 500 µl DMEM medium 
were added to upper chamber and medium containing 15% FBS was added into lower 
chamber. The cells were allowed to invade for 72 hours. The non-invading cells were 
removed by wiping and the invaded cells were first fixed with 4% paraformaldehye 
for 5 minutes followed by 20 minutes in methanol (Wako, Japan) and finally stained 
with Azure EMB geimsa (Merck, Ireland). The number of cells invaded was 
visualized under light microscope at 10x. 
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Combined Fluorescence In Situ Hybridization and 
Immunofluorescence 
Combined FISH and immunofluorescence were performed according to the 
manufacture’s protocol. Stellaris FISH probe, GFP labeled with Quasar 570 dye 
(VSMF-1018-5 Biosearch Technologies, Inc., Petaluma, CA) was used for FISH. 
Anti-FSP1 (1:300; Merck Millipore, Ireland) antibodies were used for 
immunofluorescence.   
Flow cytometry  
To isolate CD44+/CD24low cells, primary cells derived from 3 independent tumor 
samples were separately stained with monoclonal anti-CD44 (Miltenyi Biotec), 
monoclonal anti-CD24 (CD24-PE: Miltenyi Biotec), and isotype controls (Rat IgG2b-
APC and Rat IgG2b-PE) (Miltenyi Biotec) for 30 minutes on ice. The stained cells 
were analyzed using an Accuri™ flow cytometer (BD Biosciences) and FlowJo 
Software (Treestar Inc., San Carlos, CA). 
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Supplementary Table 1 
List of mouse qPCR primers used in this study. 
Gene                   Forward Primer (5’-3’)                  Reverse Primer (5’-3’) 	  
CD133        CCTTGTGGTTCTTACGTTTGTTG             GTTGACGACATTCTCAAGCTG 
EpCam       CTGGCGTCTAAATGCTTGGC                    CCTTGTCGGTTCTTCGGACTC 
Oct3/4         TCTTTCCACCAGGCCCCCGGCTC            TGCGGGCGGACATGGGGAGATCC 
Sox2            TAGAGCTAGACTCCGGGCGATGA           TTGCCTTAAACAAGACCACGAAA 
Tg Klf4        GCGAACTCACACAGGCGAGAAACC       TATCGTCGACCACTGTGCTGCTG 
Tg c-Myc     CAGAGGAGGAACGAGCTGAAGCGC      TTATCGTCGACCACTGTGCTGCTG 
FSP1             CAGGCAAAGAGGGTGACAAG                 TGCAGGACAGGAAGACACAG 
αSMA            GGAGAAGCCCAGCCAGTCGC                  AGCCGGCCTTACAGAGCCCA 
Vimentin      CGGCTGCGAGAGAAATTGC                     CCACTTTCCGTTCAAGGTCAAG 
Col1α1          GTCCTAGTCGATGGCTGCTC                    CAATGTCCAGAGGTGCAATG 
PDGFRα      ATGAGAGTGAGATCGAAGGCA               CGGCAAGGTATGATGGCAGAG 
TGFβ1          TGATACGCCTGAGTGGCTGTCT               CACAAGAGCAGTGAGCGCTGAA 
CXCL12       GAGCCAACGTCAAGCATCTG                  CGGGTCAATGCACACTTGTC 
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